Key result
Review outlines aortic bioprosthetic valve durability, mechanisms, and management of structural valve degeneration.
Why the study?
Despite the increasing use of aortic bioprostheses for aortic valve disease, structural valve degeneration limiting durability remains an important drawback of surgical and transcatheter bioprostheses.
Answers are grounded in this paper and cite their sources.
Structural valve degeneration limits bioprosthesis durability as use rises; leaves open need for standardized definitions and mechanistic insights.
In recent times, there has been a considerable increase in the use of aortic bioprostheses (vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to continue in the near future. However, the occurrence of structural valve degeneration, limiting valve durability, remains an important drawback of surgical and transcatheter bioprostheses. In this paper, we provide an overview of bioprosthetic valve durability, focusing on the definition, incidence, mechanisms, predictive factors, and management of structural degeneration of aortic bioprostheses.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐Gabella et al. (2017) conducted a review in Aortic valve disease. Aortic bioprostheses vs. Mechanical prostheses was evaluated. This review provides an overview of aortic bioprosthetic valve durability, focusing on the definition, incidence, mechanisms, predictive factors, and management of structural valve degeneration.
Synapse has enriched 10 related papers. Consider them for comparative context: